Solexa Taps New England Biolabs to Supply Reagents, Manufacture SBS Polymerase | GenomeWeb
NEW YORK (GenomeWeb News) — Solexa today said it has tapped New England Biolabs to provide it with “certain key enzymes and other reagents” for its genome-analysis system, and to manufacture its sequencing-by-synthesis polymerase.
 
Financial terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.